Back to search results

Observational Study of Immediate Lymphatic Reconstruction

This study is looking at how well a surgery called immediate lymphatic reconstruction (ILR) works. ILR is a new surgery done during lymph node removal to try and prevent lymphedema (swelling caused by fluid buildup). Researchers will follow people who have ILR to see if it helps prevent swelling in their arms. They will measure arm size, volume, and fluid levels over several years. You might be able to join if you are an adult who is a potential candidate for ILR based on your doctor's assessment before surgery. The study is currently observing 100 participants, but its recruitment status is unclear.

Study design
This is an observational study, meaning researchers will watch and collect information from 100 participants who undergo immediate lymphatic reconstruction.
What's involved
You would have your arm circumference, volume, and bioimpedance (fluid levels) measured at 3, 6, 12, 18, 24, 30, 36, 48, and 60 months after your surgery.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for up to 60 months (5 years) after their surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07227467

Prospective Assessments Following Immediate Lymphatic Reconstruction

Recruiting
Not specifiedAges 18+Observational
University of Chicago
~100 participants
Updated 2025-12-15 on ClinicalTrials.gov
What's tested:patients who are candidates for immediate lymphatic reconstruction

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
The efficacy of immediate lymphatic reconstruction (ILR) based on limb circumference of each arm
Measured over post operative study period at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months, 48 months and 60 months.
+2 more outcomes measured

Conditions

Lymphatic Reconstruction

Explore related trials

Lymphedema

Where it's being run

1 sites across 1 states
Illinois1

Study leadership

  • Summer Hanson, MD, PhD, FACS · PRINCIPAL_INVESTIGATOR · University of Chicago

Who to contact

Summer Hanson, MD, PhD, FACS
[email protected]
(773) 702-6302
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

Individuals who are not eligible for ILR based on possible nodal involvement assessed preoperatively.

What this trial measures

  • The efficacy of immediate lymphatic reconstruction (ILR) based on limb circumference of each armpost operative study period at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months, 48 months and 60 months.
  • the efficacy of immediate lymphatic reconstruction (ILR) based on volumepost operative study period at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months, 48 months and 60 months.
  • the efficacy of immediate lymphatic reconstruction (ILR) based on bioimpedance spectroscopy measurements of affected and unaffected limbs of women before and after surgery.post operative study period at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months, 48 months and 60 months.

    Bioimpedance spectroscopy is a non-invasive technology that measures total body water, and both extracellular and intracellular fluid volumes.